BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Canertinib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Canertinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

vandetanib
80 shared targets
erlotinib
73 shared targets
gefitinib
59 shared targets
cediranib
57 shared targets
foretinib
84 shared targets
saracatinib
42 shared targets
bosutinib
81 shared targets
pelitinib
56 shared targets
r
92 shared targets
defosbarasertib
43 shared targets
Loading evidence profile...

This evidence profile for Canertinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.